These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 17102124)

  • 21. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
    Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C
    Endocr Relat Cancer; 2008 Jun; 15(2):609-21. PubMed ID: 18509008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas.
    Capella C; Riva C; Cornaggia M; Chiaravalli AM; Frigerio B; Solcia E
    Pathol Res Pract; 1988 Apr; 183(2):176-87. PubMed ID: 2838831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
    Körner M; Waser B; Reubi JC
    Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and surgical treatment of extra-adrenal pheochromocytoma].
    Hiller WF; Scheumann GF; Dralle H
    Chirurg; 1993 Jan; 64(1):36-42. PubMed ID: 8436047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synchronous adrenocortical neoplasms, paragangliomas, and pheochromocytomas: syndromic considerations regarding an unusual constellation of endocrine tumors.
    LeBlanc M; Tabrizi M; Kapsner P; Hanson JA
    Hum Pathol; 2014 Dec; 45(12):2502-6. PubMed ID: 25288237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
    Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
    Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
    Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
    Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Functioning paraganglioma].
    Boneschi M; Erba M; Giuffrida GF; Mattioli A; Miani S
    Minerva Chir; 1993 Dec; 48(23-24):1399-405. PubMed ID: 8177442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas.
    Kliewer KE; Cochran AJ
    Arch Pathol Lab Med; 1989 Nov; 113(11):1209-18. PubMed ID: 2684087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine needle aspiration cytology of paraganglionic tumors.
    González-Cámpora R; Otal-Salaverri C; Panea-Flores P; Lerma-Puertas E; Galera-Davidson H
    Acta Cytol; 1988; 32(3):386-90. PubMed ID: 3376706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology of adrenal neoplasms.
    Saeger W
    Minerva Endocrinol; 1995 Mar; 20(1):1-8. PubMed ID: 7651277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.
    Juhlin CC
    Endocr Pathol; 2021 Jun; 32(2):228-244. PubMed ID: 33768452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas.
    Oudijk L; van Nederveen F; Badoual C; Tissier F; Tischler AS; Smid M; Gaal J; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger R; Favier J
    PLoS One; 2015; 10(3):e0121361. PubMed ID: 25794004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
    Stenman A; Zedenius J; Juhlin CC
    Surgery; 2019 Nov; 166(5):901-906. PubMed ID: 31239074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors.
    Kimura N; Watanabe T; Noshiro T; Shizawa S; Miura Y
    Endocr Pathol; 2005; 16(1):23-32. PubMed ID: 16000843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA flow cytometry in pheochromocytoma and paraganglioma.
    Jung WH; Yang WI; Park C; Choi IJ
    Yonsei Med J; 1992 Sep; 33(3):249-57. PubMed ID: 1292249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas.
    Amar L; Peyrard S; Rossignol P; Zinzindohoue F; Gimenez-Roqueplo AP; Plouin PF
    Ann N Y Acad Sci; 2006 Aug; 1073():383-91. PubMed ID: 17102107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.
    Sadow PM; Rumilla KM; Erickson LA; Lloyd RV
    Endocr Pathol; 2008; 19(2):97-103. PubMed ID: 18461287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
    Santarpia L; Habra MA; Jiménez C
    Horm Metab Res; 2009 Sep; 41(9):680-6. PubMed ID: 19343618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.